...
机译:系统药物敏感性测试揭示了达斯替尼或MTOR抑制剂与卵巢粒细胞瘤细胞中紫杉醇的协同生长抑制
Children's Hospital University of Helsinki and Helsinki University Hospital PO Box 20 00014;
Children's Hospital University of Helsinki and Helsinki University Hospital PO Box 20 00014;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Children's Hospital University of Helsinki and Helsinki University Hospital PO Box 20 00014;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Pathology University of Helsinki and HUSLAB Helsinki University Hospital PO Box 400 00290;
Obstetrics and Gynecology University of Helsinki and Helsinki University Hospital PO Box 140;
Obstetrics and Gynecology University of Helsinki and Helsinki University Hospital PO Box 140;
Children's Hospital University of Helsinki and Helsinki University Hospital PO Box 20 00014;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Obstetrics and Gynecology University of Helsinki and Helsinki University Hospital PO Box 140;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Institute for Molecular Medicine Finland (FIMM) University of Helsinki PO Box 20 00014 Helsinki;
Clinical Chemistry and Hematology University of Helsinki and HUSLAB Helsinki University Hospital;
机译:系统药物敏感性测试揭示了达斯替尼或MTOR抑制剂与卵巢粒细胞瘤细胞中紫杉醇的协同生长抑制
机译:纳米乳液载紫杉醇和PI3K / mTOR双重抑制剂BEZ235通过凋亡协同抑制结肠癌细胞的生长
机译:通过组合选择性PI3K / mTOR和RAS / ERK途径抑制剂协同抑制卵巢癌细胞的生长
机译:紫杉醇释放聚环氧乙烷薄膜用于药物涂层球囊对平滑肌细胞生长的抑制
机译:用于紫杉醇递送至多药耐药性卵巢癌细胞的可经皮激活的纳米颗粒。
机译:体外系统药物检测显示Carboplatin紫杉醇和alpelisib作为成年颗粒细胞肿瘤的潜在新型组合治疗
机译:体外系统药物检测显示Carboplatin,紫杉醇和alpelisib作为成年颗粒细胞肿瘤的潜在新型组合治疗